4//SEC Filing
Kim Christopher 4
Accession 0001474506-25-000096
CIK 0001894525other
Filed
May 14, 8:00 PM ET
Accepted
May 15, 6:48 PM ET
Size
7.0 KB
Accession
0001474506-25-000096
Insider Transaction Report
Form 4
Kim Christopher
DirectorChairman and CMO
Transactions
- Purchase
Common Stock, par value $0.01 per share
2025-05-13$1.82/sh+19,770$35,981→ 19,770 total - Purchase
Common Stock, par value $0.01 per share
2025-05-14$1.86/sh+7,730$14,378→ 27,500 total
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to Apimeds Pharmaceuticals US, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2)-(3) to this Form 4.
- [F2]These shares were sold in multiple transactions at prices ranging from $1.75 to $1.86, inclusive.
- [F3]These shares were sold in multiple transactions at prices ranging from $1.84 to $1.89, inclusive.
Documents
Issuer
Apimeds Pharmaceuticals US, Inc.
CIK 0001894525
Entity typeother
Related Parties
1- filerCIK 0002040022
Filing Metadata
- Form type
- 4
- Filed
- May 14, 8:00 PM ET
- Accepted
- May 15, 6:48 PM ET
- Size
- 7.0 KB